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Abstract: Static lung hyperinﬂ  ation has important clinical consequences in patients with chronic 
obstructive pulmonary disease (COPD). Given that most of these patients have respiratory and 
peripheral muscle weakness, dyspnea and functional exercise capacity may improve as a result 
of inspiratory muscle training (IMT). The present study is designed to investigate the beneﬁ  ts 
of a short outpatient program of IMT on inspiratory muscle performance, exercise capacity, 
perception of dyspnea, and the inspiratory fraction (IF). Thirty patients (24 males, 6 females) 
with signiﬁ  cant COPD (forced expiratory volume in one second [FEV1] = 46.21% ± 6.7% 
predicted, FEV1 = 33.6% ± 8.04% predicted) were recruited for this study and had 3 months 
of IMT (30 minutes/day for 6 days/week) in an outpatient clinic. Following IMT, there was a 
statistically signiﬁ  cant increase in inspiratory muscle performance (an increase of the maximal 
inspiratory pressure from 59% ± 19.1% to 79% ± 21.85% predicted; p = 0.0342), a decrease in 
dyspnea (from 5.8 ± 0.78 to 1.9 ± 0.57; p = 0.0001), an increase in the distance walked during 
the 6 minute walk test, from 245 ± 52.37 m to 302 ± 41.30 m, and ﬁ  nally an increase in the IF 
(the new prognostic factor in COPD) from 27.6 ± 9.7% to 31.4% ± 9.8%. The present study 
concludes that in patients with signiﬁ  cant COPD, IMT results in improvement in performance, 
exercise capacity, sensation of dyspnea, and moreover an improvement in the IF prognostic 
factor.
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Introduction
Chronic obstructive pulmonary disease (COPD) is deﬁ  ned as a preventable and treat-
able disease with some signiﬁ  cant extrapulmonary effects that may contribute to the 
severity in individual patients. Its pulmonary component is characterized by an airﬂ  ow 
limitation that is not fully reversible. The airﬂ  ow limitation is usually progressive, and 
associated with an abnormal inﬂ  ammatory response of the lung to noxious particles or 
gases (Celli and McNee 2004; GOLD 2006). This disease has a signiﬁ  cant impact on 
the quality of life for patients and their families, and kills millions of people world-
wide (Celli and McNee 2004; Strong et al 2005; GOLD 2006). In 2004, the American 
Thoracic Society/European Respiratory Society guidelines introduced into its deﬁ  ni-
tion the concept that, although COPD affects the lungs, it also produces signiﬁ  cant 
systemic consequences (Celli and McNee 2004).
Patients with signiﬁ  cant COPD have respiratory and peripheral muscle weakness 
(Gosselink et al 2000). Respiratory muscle weakness may contribute to dyspnea and 
to poor exercise performance (Pardy 1984; Rochester et al 1985), and for this reason, 
those patients must breathe at high lung volumes to maintain patency of their narrowed 
airways. The major abnormality of respiratory muscle function in these patients is 
thought to be the mechanical disadvantage caused by the hyperinﬂ  ation, which depresses International Journal of COPD 2008:3(3) 424
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the dome of the diaphragm, shortens its ﬁ  bers, and forces it to 
work on an ineffective portion of its length/tension curve.
In other words, both the loss of the lung’s elastic 
recoil, and the development of expiratory ﬂ  ow limitations 
promote progressive air trapping, with an increase in the 
end-expiratory lung volume and a decrease in inspiratory 
capacity (IC). Hence, this static lung hyperinﬂ  ation, and 
its increase during exercise (dynamic hyperinﬂ  ation), have 
been associated with limitations in the functional capacity 
of those patients (Diaz et al 2000; O’Donnell et al 2001). 
Therefore, we believed ventilatory muscle training in these 
patients could be beneﬁ  cial in enhancing respiratory muscle 
function and potentially reducing the severity of breathless-
ness, leading to improved exercise tolerance.
The present study was performed in order to investigate 
the effect of a short term program of IMT (inspiratory muscle 
training) on inspiratory muscle performance, the percep-
tion of dyspnea, and also its effect on the prognostic index 
(inspiratory fraction) in patients with signiﬁ  cant COPD. 
We worked with the inspiratory fraction (the ratio of IC to 
total lung capacity [TLC]), which is a noninvasive test that 
can be easily measured in a lung function laboratory (Oga 
et al 2003). This fraction reﬂ  ects not only the degree of lung 
hyperinﬂ  ation, but also the functional reserve in patients with 
COPD (Casanova et al 2005).
Patients and methods
Subjects
Our study consisted of 30 patients (24 males and 6 females) 
of moderate and severe COPD, with spirometric evidence 
of signiﬁ  cant chronic air-ﬂ  ow limitation (forced expiratory 
volume in one second (FEV1) 50% predicted, FEV1/forced 
vital capacity [FVC] 70% predicted), who were diagnosed 
as having COPD according to the criteria of the American 
Thoracic Society (1995), and were recruited from an outpa-
tient clinic for the study. Thirty eight patients were invited 
to participate in the study, but only thirty patients had agreed 
to participate, and of those subjects, 3 patients were eventu-
ally excluded.
Subjects were observed during a 4-week run-in period, 
with their regular treatment maintained to verify stability 
in their clinical and functional status. This relatively stable 
state means that our patients were out of exacerbation of 
COPD or hospitalization for this period. Their characteristics 
are summarized in Table 1. Patients with cardiac disease 
or poor compliance were excluded from the study; 3 potential 
patients were excluded out of the study due to their cardiac 
problems.
Study design
All tests were performed before the training and within 
1 week after its completion. After this, 27 subjects were 
assigned to receive speciﬁ  c inspiratory muscle training 
(SIMT). The program consists of two simultaneous parts: 
IMT at home for a period of 30 min/day for six days a 
week, and an outpatient rehabilitation program with three 
times weekly education and bicycle training. In this second 
part, patients underwent 30 minutes of exercise and educa-
tion and a 30 minute session of cycling on an ergometric 
bicycle.
With all patients, we performed several practice tests 
before obtaining the baseline value in order to correct pos-
sible training and learning effects. All data were collected by 
the same investigator, who was blinded to the patients and 
to the mode of treatment. The study protocol was approved 
by the institutional ethics committee, and informed consent 
was obtained from all the participants.
Tests
Spirometry
The FVC, FEV1, IC and TLC were measured three times 
on a computerized spirometer (MS MediSoft Module 5500; 
USA) and the results of the best trial are reported.
The IC was measured according to the protocol described 
by O’Donnell and Webb (1993), and we used the ratio 
(IC/TLC: Inspiratory Fraction) as a measure of resting 
hyperinﬂ  ation.
Table 1 Anthropometric, pulmonary, and respiratory muscle data 
at baseline of 30 COPD patients
 Study  entry  Beginning
   of  IMT*
Subjects n 30  27
Age yr  61 ± 8.87 yrs  61 ± 8.87 yrs
Sex M/F  24/6  21/6
Smoking/ nonsmoking  26/4  23/4
BMI kg, m²  24 ± 0.9  24 ± 0.9
FEV1% predicted  33.8% ± 7.69%  33.6% ± 8.04%
FVC% predicted  73.6% ± 14.3%  72.7% ± 17.7%
FEV1/FVC% predicted  45.92% ± 7.1%  46.21% ± 6.7%
TLC% predicted  115.8% + /− 4.6%  116% + /− 3%
IF% predicted  32.1% ± 4.3%  32.02% + /− 5.1%
PI max% predicted  59.2% + /− 17.3%  59% ± 19.1%
Notes: *There was a period of four weeks of run-in between the study entry and 
the beginning of IMT.
Abbreviations: BMI, body mass index; IMT, inspiratory muscle training; COPD, chronic 
obstructive pulmonary disease; FEV1, forced expiratory volume in the ﬁ  rst second; 
FEV1/FVC, Tiffeneau index; FVC, forced vital capacity; PI max, maximal inspiratory 
pressure; IF, inspiratory fraction.International Journal of COPD 2008:3(3) 425
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6 minute walk test (6 MWT)
The distance that the patient was able to walk in 6 min was 
determined in a measured corridor, as described for the 
12-min walk test by McGavin and coworkers (1976). The 
patients were instructed to walk at their fastest speed and 
to cover the longest possible distance over 6 min under the 
supervision of a physiotherapist. The test was performed 
twice, and the best result is reported.
Inspiratory muscle strength
Inspiratory muscle strength was assessed by measuring the 
maximal inspiratory pressure (PI max) at residual volume 
and total lung capacity, respectively, as previously described 
by Black and Hyatt (1969). The value obtained from the best 
of at least three efforts was used. IMT was performed using 
a threshold muscle trainer (Threshold Inspiratory Muscle 
Trainer, Health-Scan; USA).
Dyspnea
Dyspnea was assessed using a modified Borg scale 
(el-Manshawi et al 1986), which is a scale of numbers ranking 
the magnitude of difﬁ  culty in breathing ranging from 0 (non) 
to 10 (maximal). Measurement of dyspnea was taken place 
daily at the end of 30 minutes of IMT.
Training protocol
Subjects trained daily, six times a week, with each session 
consisting of 30 minutes. There were no ﬁ  xed number of 
repetitions of training for all patients, but they were requested 
to achieve as much training as possible during each session 
of IMT. Training lasted for three months, and was performed 
using a threshold inspiratory trainer. The subjects started 
breathing at a resistance equal to 15% of their PI max for 
three days. The resistance was then increased incrementally 
by 10% each two days, to reach 60% of their PI max at the end 
of the ﬁ  rst two weeks of training. SIMT was then continued 
at 60% of the PI max until the end of the training period.
Data analysis
The results are expressed as the mean ± standard deviation 
(SD). Comparisons of lung function, respiratory muscle 
strength and endurance, the results of the 6 MWT, and the 
rating of dyspnea within the group was carried out using the 
two-way repeated-measures analysis of variance.
Results
All values are expressed as mean ± SD unless stated other-
wise. Table 1 shows the relevant anthropometric and lung 
function characteristics of the 27 COPD patients. There were 
no signiﬁ  cant differences between the patients for age, body 
mass index (BMI), mean FEV1 and FVC, PI max, dyspnea, 
IF, and the 6 MWT at the beginning of the study; in other 
words, all patients initially had approximately the same 
scores for these parameters.
Spirometry
Following the IMT period, there was no signiﬁ  cant change 
in the FEV1 or in the FVC in the group of patients as shown 
in Table 2.
Inspiratory muscle strength
Following the training period there was a statistically 
signiﬁ  cant increase in the PI max in most of our patients, 
from 40 cm ± 3.6 cm to 54 cm ± 3.9 cm H²o; p  0.005. 
There was also a statistically signiﬁ  cant increase in the PI 
max predicted values, from 59% ± 19.1% to 79 ± 21.85%; 
p = 0.0342 (Table 2).
6WMT
There was a statistically signiﬁ  cant improvement in the dis-
tance walked during the 6 MWT following the training period 
in most of the patients, from 245.90 m ± 52.37 m to 302.4 m 
± 41.30 m; p = 0.0054). This increase of 57 m in the mean 
distance walked in 6 minutes is shown in Table 2.
Dyspnea
A statistically signiﬁ  cant decrease in the mean Borg score of 
dyspnea during breathing against resistance was associated 
with an increase in inspiratory muscle strength in the group 
of patients (5.8 ± 0.78 to 1.9 ± 0.57; p = 0.0001) (Table 2).
Inspiratory fraction
An increase, but not statistically signiﬁ  cant, in the ratio IF = IC/
TLC was noted following the inspiratory training period 
(from 27.6% ± 9.7% to 31.4% ± 9.8%; p = 0.4) (Table 2).
Table 2 Values* at baseline and following training for pulmonary 
function, muscle data, IF, dyspnea, and distance of 6 MWT
 Baseline  After  SIMT  p value
FEV1% predicted  33.6 ± 8.04  33.9 ± 9.6  0.849
FVC% predicted  72.7 ± 17.7  71.80 ± 18.27  0.93
FEV1/FVC% predicted  46.21 ± 6.7  47.2 ± 5.6  0.87
IF% predicted  27.6 ± 9.7  31.4 ± 9.8  0.40
PI max% predicted  59 ± 19.10  79 ± 21.85  0.0342†
Dyspnea 5.8  ± 0.78  1.9 ± 0.567  0.0001†
6 MWT  245.9 ± 52.37  302.4 ± 41.3  0.0054†
Notes: *Values are expressed as mean ± SD. †Statistically signiﬁ  cant.
Abbreviations: 6 MWT, 6 minute walk test; SD, standard deviation; SIMT, speciﬁ  ed 
inspiratory muscle training.International Journal of COPD 2008:3(3) 426
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Discussion
To our knowledge, this is the ﬁ  rst study to use the ratio IC/
TLC (IF), which is an independent predictor of all-cause and 
respiratory mortality in patients with COPD, in order to evalu-
ate the outcome of an outpatient IMT in those patients.
This study shows that in patients with signiﬁ  cant COPD, 
inspiratory muscles can be trained with improvement of 
muscle strength, as measured by the increasing of PI max. 
The improvement in the inspiratory muscle performance is 
associated with improved exercise performance and in the 
sensation of dyspnea in daily activities, with no improvement 
in FEV1 or FVC.
Respiratory muscles in COPD have considerably dif-
ferent loading patterns than other skeletal muscles. In 
limb muscles, especially lower-extremity muscles, muscle 
weakness and respiratory insufﬁ  ciency lead to inactivity and 
chronic underloading of the muscles. In contrast, respiratory 
muscles have to deal with an increased workload to breathe, 
and are thus chronically overloaded (MacIntyre 2006). These 
muscles are also compromised by hyperinﬂ  ation, produced 
by airway collapse and low elastic recoil (Similowski et al 
1991; O’Donnell 2002).
The scientiﬁ  c evidence about IMT at the present time 
is somewhat controversial. However, in a meta-analysis of 
17 articles on SIMT (Smith et al 1992), it has been shown 
that when the training stimulus was adequate to induce a 
signiﬁ  cant improvement in respiratory muscle performance 
there was a signiﬁ  cant reduction in the severity of dyspnea 
and an improved functional exercise capacity.
In the present study, it has been demonstrated that the 
improvement in the inspiratory muscle performance was 
associated with an increase in the 6 MWT distance and in 
the sensation of dyspnea during breathing against resis-
tance. Although this increase may possibly be inﬂ  uenced 
by the accompanying outpatient program, but our results 
were obtained after the end of our IMT program, and we 
did not wait until the end of the accompanying program. 
Such results parallel other studies, in which signiﬁ  cantly 
increased inspiratory muscle performance was associated 
with improved exercise tolerance and decreased dyspnea 
(Lotters et al 2002).
The perception of dyspnea is critical, but it presents a 
paradox to patients with airway obstruction. It limits daily 
activity and impairs quality of life and provides a warning 
of deterioration.
It has been shown that there is a close relationship 
between the sensation of breathlessness and respiratory 
muscle force both in healthy subjects and in patients with 
COPD who have severe lung function impairment (Patessio 
et al 1989). The respiratory muscles, like other skeletal 
muscles, can be trained (Pardy and Leith 1984), resulting in 
a signiﬁ  cant improvement in respiratory muscle performance. 
This increase in respiratory muscle performance was asso-
ciated with a decrease in the sensation of breathlessness in 
patients who had COPD with a pretraining respiratory muscle 
weakness (Patessio et al 1989).
We utilized the IF, which reﬂ  ects not only the degree 
of lung hyperinﬂ  ation but also the functional reserve in 
patients with COPD (Casanova et al 2005). Indeed, it is a 
noninvasive test that can be easily measured in a lung func-
tion laboratory (Oga et al 2003; Marquis 2002). It provides 
a descriptor of the severity of lung impairment and is thus 
an independent and excellent predictor of respiratory-related 
and other mortalities in COPD. The 25% IC/TLC value offers 
the best combined sensitivity, speciﬁ  city, positive and nega-
tive predictive value (Casanova et al 2005). The use of this 
index in our study with its improvement (from 27% to 31%) 
affords a good idea of the positive effect of our IMT in the 
life of COPD patients.
Therefore, our present study contributes additional infor-
mation to the knowledge regarding the beneﬁ  ts of IMT on 
exercise capacity and dyspnea in daily activities. It supports 
previous data that an outpatient program can provide beneﬁ  ts 
to patients with COPD.
A second important outcome of the current study, 
although comparison with an inpatient program was not 
made, is that IMT in patients with signiﬁ  cant COPD may be 
performed at home, under some supervision, with relatively 
good compliance.
The third important ﬁ  nding of the current study is the 
use of the IF for evaluating the outcome of the program 
which measured the resting hyperinﬂ  ation in patients with 
COPD and predicted the mortality of all causes in these 
groups of patients.
However, this study had some limitations. First, there was 
no control group. This was because the study was not designed 
to compare the outcome of an outpatient with an inpatient pro-
gram, or to compare inspiratory with expiratory muscle training. 
Secondly, few women were included. This low number prob-
ably reﬂ  ects the problem of underdiagnosis of COPD in women, 
and possibly the relatively late beginning of smoking among 
women. Third, we would have liked to follow our patients for a 
longer period. Fourth, the size of our population was relatively 
small, which affected the signiﬁ  cance of our results.
Finally, the current study was not designed to deter-
mine whether domiciliary IMT reduces exacerbations and International Journal of COPD 2008:3(3) 427
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hospital admissions in COPD patients. Further studies 
should be performed in order to overcome these problems 
and limitations.
Disclosure
The authors report no conﬂ  icts of interest.
References
American Thoracic Society. 1995. Standard for diagnosis and care of patients 
with COPD. Am J Respir Crit Care Med, 152:78–121.
Black LF, Hyatt RE. 1969. Maximal respiratory pressures: normal values 
and relationship to age and sex. Am Rev Respir Dis, 99:696–702.
Casanova C, Cote C, de Torres JP, et al. 2005. Inspiratory-to-total lung 
capacity ratio predicted mortality in patients with chronic obstructive 
pulmonary disease. Am J Respir Crit Care Med, 171:591–7.
Celli BR, MacNee W. 2004. Standard for diagnosis and treatment of patients 
with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 
23:932–46.
Diaz O, Villafrance C, Ghezzo H, et al. 2000. Role of inspiratory capacity 
on exercise tolerance in COPD patients with and without expiratory 
ﬂ  ow limitation at rest. Eur Respir J, 16:269–75.
El–Manshawi A, Killian KJ, Summers E, et al. 1986. Breathlessness 
during exercise with and without resistive load. J Appl Physiol, 
61:896–905.
[GOLD] Global Initiative for Chronic Obstructive Lung Disease. 2006. 
Workshop Report: Global strategy for diagnosis, management, and 
prevention of COPD. Available from http://www.goldcopd.com/.
Gosselink R, Toosters T, Decramer M. 2000. Distribution of muscle weak-
ness in patients with stable chronic obstructive pulmonary disease. 
J Cardiopulm Rehabil, 20:353–60.
Lotters F, Van Tol B, Kwakkel G, et al. 2002. Effects of controlled 
inspiratory muscle training in patients with COPD: a meta analysis. 
Eur Respir J, 20:570–6.
MacIntyre NR. 2006. Muscle dysfunction associated with chronic obstruc-
tive pulmonary disease. Respir Care, 51:840–8.
Marquis K, Debigare R, Lacasse Y, et al. 2002. Midthigh muscle cross – 
sectional area is a better predictor of mortality than body mass index 
in patients with chronic obstructive pulmonary disease. Am J Respir 
Crit Care Med, 166:809–13.
McGavin CR, Gupta SP, McHardy GJR. 1976. Twelve-minute walking test 
for assessing disability in chronic bronchitis. BMJ, 1:822–3.
O’Donnell DE, Revill SM, Webb KA. 2001. Dynamic hyperinﬂ  ation and 
exercise intolerance in chronic obstructive pulmonary disease. Am J 
Respir Crit Care Med, 164:770–7.
O’Donnell DE, Web KA. 1993. Exertional breathlessness in patients with 
chronic airﬂ  ow limitation: the role of lung hyperinﬂ  ation. Am Rev 
Respir Dis, 148:1351–7.
O’Donnell DE. 2002. Exercise limitation and clinical exercise testing in 
chronic obstructive pulmonary disease. In: Weisman IM, Zeballos RJ, 
(eds). Progress in respiratory research: Clinical exercise testing. Basel: 
Karger, pp. 138–58.
Oga T, Nishimura K, Tsukino M et al. 2003. Analysis of the factor related 
to mortality in chronic obstructive pulmonary disease. Am J Respir 
Crit Care Med, 167:544–9.
Pardy RL, Leith DE. 1984. Ventilatory muscle training. Respir Care, 
29:278–84.
Patessio A, Rampulla C, Fracchia C, et al. 1989. Relationship between the 
perception of breathlessness and inspiratory resistive loading: report 
on a clinical trial. Eur Respir J, 2:587–91.
Rochester DF, Braun NT. 1985. Determinants of maximal inspiratory 
pressure in chronic obstructive pulmonary disease. Am Rev Respir 
Dis, 132:42–7.
Similowski T, Yan S, Gauthier AP, et al. 1991. Contractile properties of the human 
diaphragm during chronic hyperinﬂ  ation. N Engl J Med, 325:917–23.
Smith K, Cook D, Guyatt GH, et al. 1992. Respiratory muscle training 
in chronic airﬂ  ow limitation: a meta – analysis. Am Rev Respir Dis, 
145:533–9.
Strong K, Mathers C, Leeder S. 2005. Preventing chronic diseases: how 
many lives can we save? Lancet, 366:1578–82.